In addition, one study on multimodal psychotherapeutic in-patient therapy for depression found it to be effective in patients with high cytokine production of IFNγ and IL-10, among others, while no significant changes were observed in the levels of other cytokines (including HMGB1) [144]. This evidence concerns the gene HMGB1 and depressive symptom measurement.